ArticleCureus2026
Novel Interlinked Suspensory Fixation Technique Demonstrates Excellent Biomechanics and Improves Patient Outcomes in Anterior Cruciate Ligament (ACL) Reconstruction With Quadriceps Tendon Autograft.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Quadriceps tendon (QT) autografts are a versatile option for primary anterior cruciate ligament reconstruction (ACLR) due to low donor site morbidity, favorable biomechanical properties, and reliable clinical outcomes. Suspensory loop fixation techniques have been described for QT graft preparation; however, concerns regarding graft strength and construct stability persist. This study aims to evaluate the biomechanical strength and report clinical outcomes of a novel interlinked adjustable loop suspensory (IAL) fixation technique for all-soft tissue QT autograft preparation for ACLR. Methods This study combined controlled laboratory biomechanical testing with retrospective clinical case series. Strengthening the Reporting of Observation Studies in Epidemiology (STROBE) guidelines for cohort studies were followed. QT tendon grafts were harvested from fresh-frozen cadaveric knee specimens and trimmed to a diameter of 9.5 mm and length of 75 mm. Grafts were prepared following the IAL technique. All grafts underwent cyclic loading of 50-250 N for 2,000 cycles at 1 Hz, followed by ultimate load to failure testing (ULTF) at a displacement rate of 0.33 mm/s. Elongation under cyclic loading, ULTF, and mode of failure were recorded. Clinical data were collected for patients undergoing primary ACLR with this graft preparation, with or without concomitant meniscus treatment. Patient-reported outcome measures (PROMs) and range of motion (ROM) data were retrospectively collected from the medical record. Results Five QT grafts underwent biomechanical testing. The mean elongation was 4.16±0.42 mm over 2000 cycles, with minimal additional elongation between cycles 1000 and 2000 (0.09±0.01 mm). Mean ULTF was 1251.41±134.78 N. Graft failure occurred at the suture-tendon interface, with two grafts breaking at the loop and three demonstrating suture tail slippages. Thirty-three skeletally mature patients were included in this study. All patients demonstrated significant and clinically meaningful improvements in pain and functional outcomes at two-year follow up, and flexion and extension ROM at the six-month follow-up. Two (6.1%) patients had recurrent ipsilateral ACL tears due to re-injury; none of the patients experienced graft failure. Conclusion This novel interlinked adjustable-loop QT graft preparation demonstrates promising biomechanical characteristics and satisfactory early clinical outcomes, supporting its use as an effective preparation technique for all-soft tissue QT autografts in ACLR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.